|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng RS, Sun KX, Zhang SW, Zeng HM and He
J: Report of cancer epidemiology in China, 2015. Zhonghua zhong liu
za zhi (Article in Chinese). 41:19–28. 2019.
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Prensner JR, Iyer MK, Sahu A, Asangani IA,
Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, et al: The long
noncoding RNA SChLAP1 promotes aggressive prostate cancer and
antagonizes the SWI/SNF complex. Nat Genet. 45:1392–1398. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang J, Hao T, Sun J, Wei P and Zhang H:
Long noncoding RNA GAS5 modulates α-Solanine-induced
radiosensitivity by negatively regulating miR-18a in human prostate
cancer cells. Biomed Pharmacother. 112:1086562019. View Article : Google Scholar
|
|
6
|
Wu M, Huang Y, Chen T, Wang W, Yang S, Ye
Z and Xi X: LncRNA MEG3 inhibits the progression of prostate cancer
by modulating miR-9-5p/QKI-5 axis. J Cell Mol Med. 23:29–38. 2019.
View Article : Google Scholar
|
|
7
|
Zhang Y, Zhang D, Lv J, Wang S and Zhang
Q: LncRNA SNHG15 acts as an oncogene in prostate cancer by
regulating miR-338-3p/FKBP1A axis. Gene. 705:44–50. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan Q, Chu H, Ge Y, Ma G, Du M, Wang M,
Zhang Z and Zhang W: LncRNA PCAT1 and its genetic variant rs1902432
are associated with prostate cancer risk. J Cancer. 9:1414–1420.
2018. View Article : Google Scholar :
|
|
9
|
Li X, Ren Y and Zuo T: Long noncoding RNA
LINC00978 promotes cell proliferation and invasion in non-small
cell lung cancer by inhibiting miR-6754-5p. Mol Med Rep.
18:4725–4732. 2018.PubMed/NCBI
|
|
10
|
Wang W, Xu Z, Wang J and Chen R: LINC00978
promotes bladder cancer cell proliferation, migration and invasion
by sponging miR-4288. Mol Med Rep. 20:1866–1872. 2019.PubMed/NCBI
|
|
11
|
Wang H, Wu M, Lu Y, He K, Cai X, Yu X, Lu
J and Teng L: LncRNA MIR4435-2HG targets desmoplakin and promotes
growth and metastasis of gastric cancer by activating Wnt/β-catenin
signaling. Aging (Albany NY). 11:6657–6673. 2019. View Article : Google Scholar
|
|
12
|
Shen X, Ding Y, Lu F, Yuan H and Luan W:
Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma
proliferation and metastasis through the miR-22-3p/YWHAZ axis. Am J
Transl Res. 12:6381–6394. 2020.PubMed/NCBI
|
|
13
|
Nguyen K, Yan Y, Yuan B, Dasgupta A, Sun
V, Mu H, Do KA, Ueno NT, Andreeff M and Battula VL: ST8SIA1
regulates tumor growth and metastasis in TNBC by activating the
FAK-AKT-mTOR signaling pathway. Mol Cancer Ther. 17:2689–2701.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shan Y, Liu Y, Zhao L, Liu B, Li Y and Jia
L: MicroRNA-33a and let-7e inhibit human colorectal cancer
progression by targeting ST8SIA1. Int J Biochem Cell Biol.
90:48–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Y, Deng X, Chen W, Shi P, Lian M,
Wang H, Wang K, Qian D, Xiao D and Long H: Silencing of
microRNA-708 promotes cell growth and epithelial-to-mesenchymal
transition by activating the SPHK2/AKT/β-catenin pathway in glioma.
Cell Death Dis. 10:4482019. View Article : Google Scholar
|
|
16
|
Sun X, Xing G, Zhang C, Lu K, Wang Y and
He X: Knockdown of Trop2 inhibits proliferation and migration and
induces apoptosis of endometrial cancer cells via AKT/β-catenin
pathway. Cell Biochem Funct. 38:141–148. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei B, Wang Y, Wang JW, Cai X, Xu L, Wu J,
Wang Y, Liu W, Gu Y, Guo W and Xu Q: Apatinib suppresses tumor
progression and enhances cisplatin sensitivity in esophageal cancer
via the Akt/β-catenin pathway. Cancer Cell Int. 20:1982020.
View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Tosoian JJ, Gorin MA, Ross AE, Pienta KJ,
Tran PT and Schaeffer EM: Oligometastatic prostate cancer:
Definitions, clinical outcomes, and treatment considerations. Nat
Rev Urol. 14:15–25. 2017. View Article : Google Scholar
|
|
20
|
Pan B, Ye Y, Liu H, Zhen J, Zhou H, Li Y,
Qu L, Wu Y, Zeng C and Zhong W: URG11 regulates prostate cancer
cell proliferation, migration, and invasion. Biomed Res Int.
2018:40607282018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bu JY, Lv WZ, Liao YF, Xiao XY and Lv BJ:
Long non-coding RNA LINC00978 promotes cell proliferation and
tumorigenesis via regulating microRNA-497/NTRK3 axis in gastric
cancer. Int J Biol Macromol. 123:1106–1114. 2019. View Article : Google Scholar
|
|
22
|
Zhang Q, Cheng S, Cao L, Yang J, Wang Y
and Chen Y: LINC00978 promotes hepatocellular carcinoma
carcinogenesis partly via activating the MAPK/ERK pathway. Biosci
Rep. 40:BSR201927902020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu H, Zhang B, Yang Y, Yang Y, Li Z, Zhao
P, Wu W, Zhang H and Mao J: LncRNA MIR4435-2HG potentiates the
proliferation and invasion of glioblastoma cells via modulating
miR-1224-5p/TGFBR2 axis. J Cell Mol Med. 24:6362–6372. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong X, Yang Z, Yang H, Li D and Qiu X:
Long non-coding RNA MIR4435-2HG promotes colorectal cancer
proliferation and metastasis through miR-206/YAP1 axis. Front
Oncol. 10:1602020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen H, Sun B, Yang Y, Cai X, Bi L, Deng L
and Zhang L: MIR4435-2HG regulates cancer cell behaviors in oral
squamous cell carcinoma cell growth by upregulating TGF-β1.
Odontology. 108:553–559. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takashima S, Matsumoto T, Tsujimoto M and
Tsuji S: Effects of amino acid substitutions in the sialylmotifs on
molecular expression and enzymatic activities of
α2,8-sialyltransferases ST8Sia-I and ST8Sia-VI. Glycobiology.
23:603–612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rimoldi S, Papis E, Bernardini G, Prati M
and Gornati R: Molecular cloning and expression of
alpha2,8-sialyltransferase (ST8Sia I, GD3 Synthase) in xenopus. Mol
Cell Biochem. 301:143–153. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamashiro S, Okada M, Haraguchi M and
Furukawa K, Lloyd KO, Shiku H and Furukawa K: Expression of alpha
2,8-sialyltransferase (GD3 synthase) gene in human cancer cell
lines: High level expression in melanomas and up-regulation in
activated T lymphocytes. Glycoconjugate J. 12:894–900. 1995.
View Article : Google Scholar
|
|
29
|
Sarkar TR, Battula VL, Werden SJ, Vijay
GV, Ramirez-Peña EQ, Taube JH, Chang JT, Miura N, Porter W, Sphyris
N, et al: GD3 synthase regulates epithelial-mesenchymal transition
and metastasis in breast cancer. Oncogene. 34:2958–2967. 2015.
View Article : Google Scholar :
|
|
30
|
Cazet A, Lefebvre J, Adriaenssens E,
Julien S, Bobowski M, Grigoriadis A, Tutt A, Tulasne D, Le Bourhis
X and Delannoy P: GD3 synthase expression enhances
proliferation and tumor growth of MDA-MB-231 breast cancer cells
through c-Met activation. Mol Cancer Res. 8:1526–1535. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Birklé S, Gao L, Zeng G and Yu RK:
Down-regulation of GD3 ganglioside and its O-acetylated derivative
by stable transfection with antisense vector against GD3-synthase
gene expression in hamster melanoma cells: Effects on cellular
growth, melanogenesis, and dendricity. J Neurochem. 74:547–554.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kang NY, Kim CH, Kim KS, Ko JH, Lee JH,
Jeong YK and Lee YC: Expression of the human CMP-NeuAc:GM3
alpha2,8-sialyltransferase (GD3 synthase) gene through the
NF-kappaB activation in human melanoma SK-MEL-2 cells. Biochim
Biophys Acta. 1769:622–630. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo M and Guan JL: Focal adhesion kinase:
A prominent determinant in breast cancer initiation, progression
and metastasis. Cancer Lett. 289:127–139. 2010. View Article : Google Scholar :
|
|
34
|
Xia H, Nho RS, Kahm J, Kleidon J and Henke
CA: Focal adhesion kinase is upstream of phosphatidylinositol
3-kinase/Akt in regulating fibroblast survival in response to
contraction of type I collagen matrices via a beta 1 integrin
viability signaling pathway. J Biol Chem. 279:33024–33034. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jindra PT, Jin YP, Rozengurt E and Reed
EF: HLA class I antibody-mediated endothelial cell proliferation
via the mTOR pathway. J Immunol. 180:2357–2366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wan H, Li Z, Wang H, Cai F and Wang L:
ST8SIA1 inhibition sensitizes triple negative breast cancer to
chemotherapy via suppressing Wnt/β-catenin and FAK/Akt/mTOR. Clin
Transl Oncol. 23:902–910. 2020. View Article : Google Scholar
|
|
37
|
Qiao M, Iglehart JD and Pardee AB:
Metastatic potential of 21T human breast cancer cells depends on
Akt/protein kinase B activation. Cancer Res. 67:5293–5299. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang X, Chen T, Zhang J, Mao Q, Li S,
Xiong W, Qiu Y, Xie Q and Ge J: Notch1 promotes glioma cell
migration and invasion by stimulating β-catenin and NF-κB signaling
via AKT activation. Cancer Sci. 103:181–190. 2012. View Article : Google Scholar
|
|
39
|
Liu J, Liu L, Chao S, Liu Y, Liu X, Zheng
J, Chen J, Gong W, Teng H, Li Z, et al: The role of
miR-330-3p/PKC-α signaling pathway in low-dose endothelial-monocyte
activating polypeptide-II increasing the permeability of
blood-tumor barrier. Front Cell Neurosci. 11:3582017. View Article : Google Scholar
|
|
40
|
Liu DC, Song LL, Liang Q, Hao L, Zhang ZG
and Han CH: Long noncoding RNA LEF1-AS1 silencing suppresses the
initiation and development of prostate cancer by acting as a
molecular sponge of miR-330-5p via LEF1 repression. J Cell Physiol.
234:12727–12744. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Q, Wang W, Zhang M, Sun W, Shi W and Li
F: Circular RNA circ-0016068 promotes the growth, migration, and
invasion of prostate cancer cells by regulating the
miR-330-3p/BMI-1 axis as a competing endogenous RNA. Front Cell Dev
Biol. 8:8272020. View Article : Google Scholar : PubMed/NCBI
|
